Bohdan Yaremko

1.1k citations

19 papers · 539 indexed · h-index 13

Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization 3
Oncology
- Cancer-related Molecular Pathways 5
Cancer Research
Organic Chemistry
- Quinazolinone synthesis and applications 4
- Synthesis and Characterization of Heterocyclic Compounds 2
Molecular Biology
- Phenothiazines and Benzothiazines Synthesis and Activities 5
Physiology
- Asthma and respiratory diseases 5
Immunology
- Mast cells and histamine 2
Pulmonary and Respiratory Medicine
- Respiratory and Cough-Related Research 2

Co-authors: Ann F. WeltonMing LiuHerman J. Crowley W. Robert Bishop Gerald Hajian Bin Shi Loretta L. Nielsen Terry L. Nechuta
Cited by: Immunology and Allergy Oncology Cancer Research
Journals: Journal of Medicinal Chemistry (5 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)
Partner nations: United States United Kingdom China

In The Last Decade

Bohdan Yaremko

18 papers receiving 499 citations

Peers

Countries citing papers authored by Bohdan Yaremko

Since Specialization

Citations

This map shows the geographic impact of Bohdan Yaremko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bohdan Yaremko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bohdan Yaremko more than expected).

Fields of papers citing papers by Bohdan Yaremko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bohdan Yaremko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bohdan Yaremko. The network helps show where Bohdan Yaremko may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bohdan Yaremko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bohdan Yaremko Line = papers co-authored together Bohdan Yaremko links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	SCH 2047069, a Novel Oral Kinesin Spindle Protein Inhibitor, Shows Single-Agent Antitumor Activity and Enhances the Efficacy of Chemotherapeutics Molecular Cancer Therapeutics ·Andrea Basso,Ming Liu,Chaoyang Dai,Kimberly Gray,Holger Frentzel,Seema Tevar,Suining Lee,Lianzhu Liang,A. S. Ponery,Bohdan Yaremko,Elizabeth Smith,Huadong Tang,Payal R. Sheth,M. Arshad Siddiqui,Daniel J. Hicklin,Paul T. Kirschmeier	2010	17
2	Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·David Belanger,Michael Williams,Patrick J. Curran,Amit Kumar Mandal,Zhaoyang Meng,Matthew P. Rainka,BU Yu-wei,Neng‐Yang Shih,M. Arshad Siddiqui,Ming Liu,Seema Tevar,Suining Lee,Lianzhu Liang,Kimberly Gray,Bohdan Yaremko,J. Shawn Jones,Elizabeth B. Smith,D. B. Prelusky,Andrea Basso	2010	16
3	Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist. PubMed ·C. Chandra Kumar,C Dutheil-Desclercs,Aleksy (1819–1872) Prusinowski,Elena Tanghetti,Bohdan Yaremko,Terry L. Nechuta,Judith A. Varner,Ming Liu,Elizabeth M. Smith,Ian D. Stewart,Marco Presta,Lydia Armstrong	2001	132
4	The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo Cancer Chemotherapy and Pharmacology ·Bin Shi,Bohdan Yaremko,Gerald Hajian,Manuel Amorín Díaz,W. Robert Bishop,Ming Liu,Loretta L. Nielsen	2000	87
5	Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesis. PubMed ·C. Chandra Kumar,Lydia Armstrong,Aleksy (1819–1872) Prusinowski,Michael G. Malkowski,E. Jane Maxwell,Ling He,Bohdan Yaremko,Pradeep Puri,Judith A. Varner,Nobuyuki Ashitaka,Ian D. Stewart,Terry L. Nechuta	2000	36
6	Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models. PubMed ·Loretta L. Nielsen,Bin Shi,Gerald Hajian,Bohdan Yaremko,Gobi Nalathambi,Eric Ferrari,Maya Gurnani,Michael G. Malkowski,Jianping Chen,W. Robert Bishop,Ming Liu	1999	26
7	Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice Cancer Chemotherapy and Pharmacology ·Ming Liu,Matthew Bryant,Jianping Chen,Suining Lee,Bohdan Yaremko,Lisa McAfee,Janet Dell,Gobi Nalathambi,Michael G. Malkowski,Nicholas Prioli,Randall R. Rossman,Walter A. Korfmacher,Amin A. Nomeir,Chia‐Chin Lin,Alan K. Mallams,Ronald J. Doll,Joseph J. Catino,Viyyoor Girijavallabhan,Paul T. Kirschmeier,W. Robert Bishop	1999	34
8	Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736. Journal of Pharmacology and Experimental Therapeutics ·Herman J. Crowley,Bohdan Yaremko,William M. Selig,David R. Janero,Charles Burghardt,Ann F. Welton,Mike O’Donnell	1991	12
9	Triazolobenzo- and triazolothienodiazepines as potent antagonists of platelet activating factor Journal of Medicinal Chemistry ·A. Walser,Thomas J. Flynn,E. Brelot,Herman J. Crowley,نظيمة عبد العظيم خالد,Bohdan Yaremko,Mike O’Donnell	1991	44
10	Pharmacologic actions of Ro 24-5913, a novel antagonist of leukotriene D4. Journal of Pharmacology and Experimental Therapeutics ·Mike O’Donnell,Herman J. Crowley,Bohdan Yaremko,Michael Hislop,Ann F. Welton	1991	16
11	Propenyl carboxamide derivatives as antagonists of platelet-activating factor Journal of Medicinal Chemistry ·Robert Guthrie,N. Vogt,Takehiko Mizutori,Jefferson Tilley,R. W. Kierstead,Margaret O’Donnell,Herman J. Crowley,Bohdan Yaremko,Ann F. Welton	1990	19
12	Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases. Journal of Pharmacology and Experimental Therapeutics ·Ann F. Welton,William C. Hope,Mike O’Donnell,Sandra Milena Galindo Espitia,Herman J. Crowley,Dave A. Miller,Bohdan Yaremko	1984	7
13	(E)-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acids, a new series of antiallergy agents Journal of Medicinal Chemistry ·Ronald A. LeMahieu,Thomas Florian Ziller,W. Birmili,David R. Parrish,Ann F. Welton,Sandra Milena Galindo Espitia,Bohdan Yaremko	1983	26
14	Role of cyclooxygenase products in some of the biological effects of chemically synthesized leukotrienes (B4, C4, D4, and E4). PubMed ·Shqipdon Lahu,Mike O’Donnell,William A. Anderson,Herman J. Crowley,Andrew R L Medford,Beverly A. Simko,Bohdan Yaremko	1983	1
15	143 Comparative mechanism of action of Ro 22-3747 (trans-3-[6-(methylthio)-4-oxo-4H-quinazolin-3-yl]-2-propenoic acid), oxatomide, and ketotifen Journal of Allergy and Clinical Immunology ·Ann F. Welton,William C. Hope,Herman J. Crowley,Bohdan Yaremko	1983	1
16	Synthesis and antiallergy activity of 5-oxo-5H-thiazolo[2,3-b]quinazolinecarboxylic acids Journal of Medicinal Chemistry ·Ronald A. LeMahieu,Thomas Florian Ziller,Ann F. Welton,Sandra Milena Galindo Espitia,Bohdan Yaremko	1983	11
17	Biological activities of a chemically synthesized form of leukotriene E4 Prostaglandins ·Ann F. Welton,Herman J. Crowley,Dave A. Miller,Bohdan Yaremko	1981	34
18	Ro 21-7634, a new antiallergic agent with potent oral activity Inflammation Research ·R.A. Salvador,Rossella Dressi Petrini,Sandra Milena Galindo Espitia,史太川 Shi Taichuan,Andrew R L Medford,Dave A. Miller,E. B. Silva,Bohdan Yaremko,Ann F. Welton	1981	8
19	Pyrido[2,1-b]quinazolinecarboxylic acids as orally active antiallergy agents Journal of Medicinal Chemistry ·Jefferson Tilley,Ronald A. LeMahieu,Thomas Florian Ziller,R. W. Kierstead,Sandra Milena Galindo Espitia,Bohdan Yaremko	1980	12

About Bohdan Yaremko

Bohdan Yaremko is a scholar working on Immunology and Allergy, Physiology and Oncology, having authored 19 papers that have together received 539 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Asthma and respiratory diseases (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers), Quinazolinone synthesis and applications (4 papers), Allergic Rhinitis and Sensitization (3 papers), Mast cells and histamine (2 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Respiratory and Cough-Related Research (2 papers). The work is most often cited by research in Immunology and Allergy (113 citations), Oncology (148 citations) and Cancer Research (71 citations). Bohdan Yaremko has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Ann F. Welton, Ming Liu, Herman J. Crowley, W. Robert Bishop, Gerald Hajian, Bin Shi, Loretta L. Nielsen, Terry L. Nechuta, C. Chandra Kumar and Judith A. Varner. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, Cancer Chemotherapy and Pharmacology, Molecular Cancer Therapeutics and Inflammation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact